Diabetes type2. E11
Conditions
Interventions
Intervention 1: Treatment group will receive Spirulina concentrate powder, product of Nano chemical cell company, at dose of 8 grams in 3 divided dose per day for 3 months in addition to their previou
Treatment - Drugs
Control group recieve their previous diabetes drugs.
Treatment group will receive Spirulina concentrate powder, product of Nano chemical cell company, at dose of 8 grams in 3 divided dose per day for 3 months in addition to their previous drugs.
Sponsors
Vice Chancellor for research of Ferdowsi University of Mashhad
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: The age range of 30-60 years old; Type II Diabetic patients ; Disease duration 5-10 years ; Fasting blood glucose 126-300 milligram per deciliter ; Hemoglobin A1c more than 7 Exclusion criteria: Smoking; Develop other underlying medical condition ; Pregnancy and Breastfeeding
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma glucose. Timepoint: 0 and 30 days and 60 days and 90 days after intervention. Method of measurement: milligrams per deciliter by Autoanalyser.;Hemoglubin A1c. Timepoint: At 0 and 90 days after intervention. Method of measurement: milligrams per deciliter by NycoCard. | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver function tests. Timepoint: every 3 month. Method of measurement: Auto analyzer kits. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMelika Beihaghi
Ferdowsi University of Mashhad
Outcome results
None listed